Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00940381
Title Sirolimus and Cetuximab in Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

colorectal cancer

Therapies

Cetuximab + Sirolimus

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.